Sleep Disorders Trial, Recruiting NCT05739617 Sponsor: National Cheng-Kung University Hospital Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05739617
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have recently been diagnosed with obstructive sleep apnea (OSA), with a sleep test result showing 5 or more breathing interruptions per hour
  • People aged between 20 and 65 years old
  • People with a body mass index (a measure of body weight relative to height) between 18 and 30

Who may not be able to join:

  • People diagnosed with a type of sleep apnea where the brain, rather than a physical blockage, causes the breathing interruptions (central or mixed sleep apnea)
  • People with a disease that affects the nerves or muscles
  • People with serious heart or blood vessel disease
  • People with a currently active mental health condition
  • People with a disease or cancer affecting the head or neck
  • People with physical structural problems in the upper airway (the nose, mouth, or throat area)
  • People who have previously had surgery or medical treatment on their neck
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ching-Hsia Hung, PhD, National Cheng Kung University

Phone: +886-9-37839992

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Cheng-Kung University Hospital
Registry
ClinicalTrials.gov
Start date
1 March 2023
Est. completion
20 May 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Change in Apnea-Hypopnea Index (AHI); Change in Oxygen Desaturation Index (ODI); Change in Maximum Oxygen Consumption (Vo2max); Change in Tongue Muscle Thickness; Change in Tongue Muscle Stiffness; Change in Tongue Muscle Strength; Change in Tongue Muscle Endurance; Change in Jaw strength; Change in Pharyngeal Airway Volume; Change in Cross Section Area on the Tip of Epiglottis; Change in Anterior to Posterior Distance on the Tip of the Epiglottis; Change in Lateral Distance on the Tip of Epiglottis; Change in daytime sleepiness; Change in Drug-induced Sleep Endoscopy (DISE); Change in sleep q...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov